PDT-enhanced anti-tumor immunity is mediated by CD8+ cytotoxic T cells (CTLs) [3, 4] and is accompanied by enhanced CTL-mediated tumor cytotoxicity, formation of immune memory cells, and resistance to subsequent tumor growth [5]. The gene discussed is CD8A; the disease is neoplasm.